Pathways to Access & Reimbursement

Offering a critical analysis of Canada’s access and reimbursement environment, and in-depth discussions on how to adapt market access strategies — especially at a time when affordability and overall health system sustainability are top of mind.

WHO ATTENDS

Practitioners at every level with experience in:

Pricing
Reimbursement
Market access
Patient access
Government and regulatory affairs
Health economics
Research and development
Policy and compliance
Pharmacy services
Marketing
National trade
Formularies
Business development
Sales

From brand generic and manufacturing companies involved in:

Product development
Public drug programs
Pharmaceutical benefits
Pharmaceutical strategy
Drug submissions
Formulary management
Policy and economic analysis
Provider services and
relations
Pharmacy

And representatives from:

Associations
Patient Advocacy Groups

About this Conference

The COVID-19 pandemic has exacerbated time and budgetary constraints leaving market access strategies in a precarious place. At the same time, the National Pharmacare program and PMPRB reforms continue to unfold slowly, with many questions yet to be answered about how these pieces will form a cohesive approach to improved access and affordability without sacrificing innovation.

This annual forum will host critical conversations, examining the most vexing questions and challenges hovering over manufacturers, payers, and patient groups alike, while also exploring opportunities to empower decision-making so that the right treatment reaches patients at the right time.

Join us at this highly anticipated market access event to share best practices, participate in candid discussions, and hear the latest developments from leading drug manufacturers and other industry leaders.